Global Custom Market Research Reports Provider Company


iX Biopharma Ltd (42C) - Financial and Strategic SWOT Analysis Review

  • Published Date: 09 Mar 2018
  • Number of Pages: 25
  • Category: Pharmaceuticals
  • Country: Singapore

iX Biopharma Ltd (iX Biopharma) is a pharmaceutical company that provides that offers drug delivery and formulation. The companys pipeline product portfolio includes development of drugs for various indications such as opioid-sparing for acute, severe and chronic pain; male erectile dysfunction and pain management for cancer. It utilizes its multiple platform technology, WaferiX that helps to reduce the loss of drugs due to hepatic and gastrointestinal metabolism to improve bioavailability of the drugs. iX Biopharma develops drugs for analgesics and mens health. The company conducts its research and development activities in Singapore and Australia. It also operates through a manufacturing facility in Australia. iX Biopharma is headquartered in Singapore.

iX Biopharma Ltd Key Recent Developments

Feb 08,2018: iX Biopharma Secures Chinese Patent for WaferiX
Jan 04,2018: Bod signs Exclusive Manufacturing and Commercialisation Agreement with iX Biopharma
Nov 08,2017: IX Biopharma Starts Off 1Q18 on Sound Note
Oct 23,2017: iX Biopharma Secures European Patent For Waferix Drug Delivery Technology
Aug 23,2017: iX Biopharma: Unaudited Financial Statements for the Fourth Quarter and Financial Year Ended 30 June 2017

This comprehensive SWOT profile of iX Biopharma Ltd provides you an in-depth strategic analysis of the companys businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalDatas Profile on Demand service, covering over 50,000 of the worlds leading companies. Once purchased, GlobalDatas highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of iX Biopharma Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief Summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Publisher Name : GlobalData

Section 1 - About the Company

iX Biopharma Ltd - Key Information
iX Biopharma Ltd - Overview
iX Biopharma Ltd - Key Employees
iX Biopharma Ltd - Key Employee Biographies
iX Biopharma Ltd - Key Operational Heads
iX Biopharma Ltd - Major Products and Services
iX Biopharma Ltd - History
iX Biopharma Ltd - Company Statement
iX Biopharma Ltd - Locations And Subsidiaries
iX Biopharma Ltd - Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 - Company Analysis

iX Biopharma Ltd - Business Description
iX Biopharma Ltd - Corporate Strategy
iX Biopharma Ltd - SWOT Analysis
SWOT Analysis - Overview
iX Biopharma Ltd - Strengths
iX Biopharma Ltd - Weaknesses
iX Biopharma Ltd - Opportunities
iX Biopharma Ltd - Threats
iX Biopharma Ltd - Key Competitors

Section 3 - Company Financial Performance Charts

iX Biopharma Ltd - Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

Section 4 - Appendix

Ratio Definitions
About GlobalData
Contact Us

Note*: Some sections may be missing if data is unavailable for the company

List Of Tables

List of Tables

iX Biopharma Ltd, Key Information
iX Biopharma Ltd, Key Ratios
iX Biopharma Ltd, Share Data
iX Biopharma Ltd, Major Products and Services
iX Biopharma Ltd, History
iX Biopharma Ltd, Key Employees
iX Biopharma Ltd, Key Employee Biographies
iX Biopharma Ltd, Key Operational Heads
iX Biopharma Ltd, Other Locations
iX Biopharma Ltd, Subsidiaries
iX Biopharma Ltd, Key Manufacturing facilities
iX Biopharma Ltd, Key Competitors
iX Biopharma Ltd, SWOT Analysis
iX Biopharma Ltd, Ratios based on current share price
iX Biopharma Ltd, Annual Ratios
iX Biopharma Ltd, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

List of Figures

iX Biopharma Ltd, Performance Chart
iX Biopharma Ltd, Ratio Charts

72 kDa Type IV Collagenase (Matrix Metalloproteinase 2 or Gelatinase A or Neutrophil Gelatinase or 72 kDa Gelatinase or TBE 1 or MMP2 or EC - Pipeline Review, H2

View Report

IXICO Plc (IXICO), formerly Phytopharm plc is a provider of clinical trial services and technology for the evaluation of imaging endpoints and assessing the safety and efficacy of drugs. The

View Report

Metal matrix composites (MMCs) is a composite material consisting of an essential metal reinforcement with a second constituent which may be a different metal or non-metallic material such as ceramic

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports